This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ultra V Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: An Overview of Byeung Mo Chang's Innovations in Medical Fillers
Introduction
Byeung Mo Chang is an innovative inventor based in Seoul, South Korea. He has made significant strides in the field of medical technology, particularly with his work on polydioxanone particles. His contributions have the potential to advance regenerative medicine and enhance skin treatment options.
Latest Patents
Byeung Mo Chang holds a patent for a method of manufacturing polydioxanone particles intended for use as a filler. The patent describes a precise method that includes mixing a solution of polydioxanone dissolved in perfluoroalcohol with a polymer emulsion, consisting of a polyethylene oxide-polypropylene oxide-polyethylene oxide terpolymer. This careful process generates polydioxanone particles, which are subsequently recovered through aging and washing. The manufactured particles are especially useful in injections for regenerating skin tissues.
Career Highlights
Chang is associated with Ultra V Co., Ltd., where he applies his expertise in medical technologies and materials science. His dedication to innovation has led to the development of advanced solutions for aesthetic and medical applications, enhancing the quality of treatments available for skin regeneration. His singular patent underscores the impact of his scientific endeavors in the field.
Collaborations
Throughout his career, Byeung Mo Chang has worked alongside notable colleagues such as Myung Sik Choi and Sang Jin Kim. These collaborations reflect a strong team dynamic that fuels innovative projects and research initiatives. The combined expertise of these professionals plays a crucial role in pushing the boundaries of medical technology.
Conclusion
In summary, Byeung Mo Chang's contributions to the field of medical fillers through his innovative patent for polydioxanone particles demonstrate his commitment to advancing regenerative techniques. His work at Ultra V Co., Ltd. and collaborations with esteemed coworkers highlight the importance of teamwork in achieving breakthroughs in the medical industry. As research continues, Chang's inventions may lead to improved treatments and techniques for skin tissue regeneration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile